Finished Pharmaceutical
Formulations

Diabetic RangeSingle

"Glimepiride Img. Pioglitazone Hcl 1Smg + Metformin Hcl (Extended Released) 500mg Tablets (uncoatedbilayered)"

Bilayered Tablet

"Glimepiride Img. Pioglitazone Hcl 1Smg + Metformin Hcl (Extended Released) 500mg Tablets (uncoatedbilayered)" is a bilayered tablet formulated with "Glimepiride Img. Pioglitazone Hcl 1Smg + Metformin Hcl (Extended Released) 500mg (uncoatedbilayered)". Th

Available strengths

"Glimepiride Img. Pioglitazone Hcl 1Smg + Metformin Hcl (Extended Released) 500mg (uncoatedbilayered)"

Diabetic RangeSingle

Dapagliflozin 10 mg + Metformin IP S00 mg (Film coated Tablet)

Tablet

Dapagliflozin 10 mg + Metformin IP S00 mg (Film coated Tablet) is a tablet formulated with Dapagliflozin 10 mg + Metformin IP S00 mg ( ). The listed active ingredient profile is Dapagliflozin; Metformin S00 mg, placing the product in the oral antidiabetic

Available strengths

Dapagliflozin 10 mg + Metformin IP S00 mg ( )

Diabetic RangeSingle

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg (Film coated bilayred Tablet)

Tablet

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg (Film coated bilayred Tablet) is a tablet formulated with Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg ( ). The listed active ingredient profile is Dapagliflozin; Metformin Hydrochloride, plac

Available strengths

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg ( )Dapagliflozin 5 mg + Metformin Hydrochloride IP 1000 mg ( )

Diabetic RangeSingle

Dapagliflozin 5mg Tablets (Film coated)

Tablet

Dapagliflozin 5mg Tablets (Film coated) is a tablet formulated with Dapagliflozin 5mg ( ). The listed active ingredient profile is Dapagliflozin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowe

Available strengths

Dapagliflozin 5mg ( )Dapagliflozin 10mg ( )

Diabetic RangeSingle

Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg

Tablet

Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg is a tablet formulated with Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg. The listed active ingr

Available strengths

Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg

Diabetic RangeSingle

Gliclazide 80mg + Metformin hydrochloride 500mg Tablets (Uncoated Blayered)

Tablet

Gliclazide 80mg + Metformin hydrochloride 500mg Tablets (Uncoated Blayered) is a tablet formulated with Gliclazide 80mg + Metformin hydrochloride 500mg ( Blayered). The listed active ingredient profile is Gliclazide; Metformin hydrochloride, placing the p

Available strengths

Gliclazide 80mg + Metformin hydrochloride 500mg ( Blayered)

Diabetic RangeSingle

Gliclozide 80mg + Metformin hydrochloride 800mg Tablets (enterlc coated)

Tablet

Gliclozide 80mg + Metformin hydrochloride 800mg Tablets (enterlc coated) is a tablet formulated with Gliclozide 80mg + Metformin hydrochloride 800mg (enterlc coated). The listed active ingredient profile is Gliclozide; Metformin hydrochloride, placing the

Available strengths

Gliclozide 80mg + Metformin hydrochloride 800mg (enterlc coated)

Diabetic RangeSingle

Glimepiride 2mg + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered)

Bilayered Tablet

Glimepiride 2mg + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg + Metformin HCI (SR) 500mg . ( ). The listed active ingredient profile is Glimepiride; Metformin HCI, placing the product in the ora

Available strengths

Glimepiride 2mg + Metformin HCI (SR) 500mg . ( )Glimepiride 2mg + Metformin HCI (SR) 1000 mg . ( )

Diabetic RangeSingle

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered)

Bilayered Tablet

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg IP ( ). The listed active ingredient profile is Glimepiride; Metf

Available strengths

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg IP ( )

Diabetic RangeSingle

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered)

Tablet

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered) is a tablet formulated with Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered). The listed active ingredient profile is Glimepiride; Metformin

Available strengths

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered)

Diabetic RangeSingle

Glimepiride 2mg Tab. (Uncoated)

Tablet

Glimepiride 2mg Tab. (Uncoated) is a tablet formulated with Glimepiride 2mg . ( ). The listed active ingredient profile is Glimepiride, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medic

Available strengths

Glimepiride 2mg . ( )

Diabetic RangeSingle

Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg Tablets (Uncoated Bilayered)

Bilayered Tablet

Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg ( ). The listed active ingredient pr

Available strengths

Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg ( )

Diabetic RangeSingle

Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg Tablets (uncoted bilayered)

Bilayered Tablet

Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg Tablets (uncoted bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg (uncoted ). The listed acti

Available strengths

Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg (uncoted )

Diabetic RangeSingle

Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg Tablets (uncoted bilayered)

Bilayered Tablet

Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg Tablets (uncoted bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg (uncoted ). The listed acti

Available strengths

Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg (uncoted )

Diabetic RangeSingle

Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg

Tablet

Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg is a tablet formulated with Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg. The listed active ingredient profile is Glimepiride; Metformin Hydrochloride, placing the product in the oral antidiabet

Available strengths

Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg

Diabetic RangeSingle

Glimepiride Img + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered)

Bilayered Tablet

Glimepiride Img + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride Img + Metformin HCI (SR) 500mg . ( ). The listed active ingredient profile is Glimepiride Img; Metformin HCI, placing the product in the

Available strengths

Glimepiride Img + Metformin HCI (SR) 500mg . ( )Glimepiride Img + Metformin HCI(SR) 1000 mg . ( )

Diabetic RangeSingle

Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered)

Bilayered Tablet

Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg IP ( ). The listed active ingredient profile is Glimepiride Img;

Available strengths

Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg IP ( )

Diabetic RangeSingle

Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered)

Tablet

Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered) is a tablet formulated with Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered). The listed active ingredient profile is Glimepiride Img; Metfo

Available strengths

Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered)

Diabetic RangeSingle

Glimepiride Img Tab. (Uncoated)

Tablet

Glimepiride Img Tab. (Uncoated) is a tablet formulated with Glimepiride Img . ( ). The listed active ingredient profile is Glimepiride Img, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering m

Available strengths

Glimepiride Img . ( )

Diabetic RangeSingle

Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg (Uncoated bilayered Tablet)

Bilayered Tablet

Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg (Uncoated bilayered Tablet) is a bilayered tablet formulated with Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg ( ). The listed active ingredient profile is Glimepiride; Metformin Hydrochlori

Available strengths

Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg ( )

Diabetic RangeSingle

Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg Tablets (Uncoated Bilayered)

Bilayered Tablet

Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg ( ). The listed active ingredient prof

Available strengths

Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg ( )

Diabetic RangeSingle

Glimepiride lP 4 mg + Metformin IP 1000 mg (Uncoated bilayered Tablet)

Bilayered Tablet

Glimepiride lP 4 mg + Metformin IP 1000 mg (Uncoated bilayered Tablet) is a bilayered tablet formulated with Glimepiride lP 4 mg + Metformin IP 1000 mg ( ). The listed active ingredient profile is Glimepiride lP; Metformin, placing the product in the oral

Available strengths

Glimepiride lP 4 mg + Metformin IP 1000 mg ( )

Diabetic RangeSingle

Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg

Tablet

Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg is a tablet formulated with Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg. The listed active ingredient profile is Glimepirlde; Metformin Hydrochloride, placing the product in the oral antidiab

Available strengths

Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg

Diabetic RangeSingle

Glipizide 5 mg + Metformin 500 mg Tablets (Uncoated Tab)

Tablet

Glipizide 5 mg + Metformin 500 mg Tablets (Uncoated Tab) is a tablet formulated with Glipizide 5 mg + Metformin 500 mg ( ). The listed active ingredient profile is Glipizide; Metformin, placing the product in the oral antidiabetic category. The formulatio

Available strengths

Glipizide 5 mg + Metformin 500 mg ( )

Diabetic RangeSingle

Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg Tablet (ilm coated)

Tablet

Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg Tablet (ilm coated) is a tablet formulated with Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg (ilm coated). The listed active ingredien

Available strengths

Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg (ilm coated)